Cargando…
Bleomycin‐induced flagellate hyperpigmentation
A 27‐year old male with Hodgkin's lymphoma was treated with combined chemotherapy that included bleomycin. He presented with pruritic erythematous, edematous linear lesions and was diagnosed to have flagellate hyperpigmentation, a rare side effect of bleomycin chemotherapy.
Autores principales: | Larson, Krista N., Gagnon, Amy L., Wilson, Barbara B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378868/ https://www.ncbi.nlm.nih.gov/pubmed/28396762 http://dx.doi.org/10.1002/ccr3.831 |
Ejemplares similares
-
Bleomycin-induced flagellate dermatitis
por: Mota, Guilherme Devidé, et al.
Publicado: (2014) -
A Danish case of bleomycin‐induced flagellate erythema
por: Soerensen, Christian A. S., et al.
Publicado: (2020) -
Bleomycin-Induced Flagellate Dermatitis
por: Turan Erkek, Esra, et al.
Publicado: (2019) -
Flagellate erythema induced by bleomycin toxicity
por: Appaji, L., et al.
Publicado: (2013) -
Bleomycin-Induced Flagellate Dermatitis: Revisited
por: Verma, Pallavi, et al.
Publicado: (2022)